| 1 | Approve Financial Statements | Abstain |
| 2 | Approve the Dividend | For |
| 3 | Approve Consolidated Financial Statements and Statutory Reports
| Abstain |
| 4 | Approve Auditors' Special Report on Related-Party Transactions Mentionning the Absence of New Transactions
| For |
| 5 | Authorise Share Repurchase | Oppose |
| 6 | Approve Remuneration Policy of General Managers
| Oppose |
| 7 | Approve Remuneration Policy of Supervisory Board Members
| For |
| 8 | Approve Compensation Report of Corporate Officers
| Oppose |
| 9 | Approve Compensation of Florent Menegaux, General Manager
| Oppose |
| 10 | Approve Compensation of Yves Chapo, Manager
| Oppose |
| 11 | Approve Compensation of Barbara Dalibard, Chair of Supervisory Board Since 21 May 2021
| For |
| 12 | Approve Compensation of Michel Rollier, Chair of Supervisory Board Until 21 May 2021
| For |
| 13 | Elect Thierry Le Hénaff - Senior Independent Director | For |
| 14 | Elect Monique Leroux - Non-Executive Director | Abstain |
| 15 | Elect Jean-Michel Severino - Non-Executive Director | For |
| 16 | Approve Remuneration of Supervisory Board Members in the Aggregate Amount of EUR 950,000
| For |
| 17 | Renew Appointment of PricewaterhouseCoopers Audit as Auditor
| Oppose |
| 18 | Renew Appointment of Deloitte & Associes as Auditor
| Oppose |
| 19 | Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to Aggregate Nominal Amount of EUR 125 Million
| For |
| 20 | Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 35 Million
| Oppose |
| 21 | Approve Issuance of Equity or Equity-Linked Securities for Private Placements, up to Aggregate Nominal Amount of EUR 35 Million
| Oppose |
| 22 | Authorize Board to Set Issue Price for 10 Percent Per Year of Issued Capital Pursuant to Issue Authority without Preemptive Rights
| Oppose |
| 23 | Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Under Items 19 to 22
| Oppose |
| 24 | Authorize Capitalization of Reserves of Up to EUR 80 Million for Bonus Issue or Increase in Par Value
| For |
| 25 | Authorize Capital Increase of up to 10 Percent of Issued Capital for Contributions in Kind
| For |
| 26 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans
| Oppose |
| 27 | Limit Authorised Capital | For |
| 28 | Authorize Decrease in Share Capital via Cancellation of Repurchased Shares
| For |
| 29 | Approve 4-for-1 Stock Split and Amend Bylaws Accordingly
| For |
| 30 | Authorize Filing of Required Documents/Other Formalities
| For |
